Parkinson's Disease Treatment News | Boehringer Ingelheim

18.06.2010	Boehringer Ingelheim receives European approval for two new strengths for the once daily tablet formulation of Mirapexin®/Sifrol® prolonged-release for the treatment of Parkinson’s disease - For non-US Healthcare Media
14.10.2009	Boehringer Ingelheim receives approval from the European Commission for Mirapexin®/Sifrol® prolonged-release, once daily tablet for the treatment of Parkinson`s disease - For medical media, outside the US only
26.06.2009	Boehringer Ingelheim receives positive recommendation from European scientific committee for a new once daily Mirapexin (pramipexole) formulation for the treatment of Parkinson`s disease - For medical media, outside the US only
10.06.2009	New data once more show high therapeutic benefits of Boehringer Ingelheim`s Mirapexin®/Sifrol® (pramipexole) once-daily extended release formulation, also in patients with advanced Parkinson`s disease - For medical media, outside the US only
30.04.2009	Outcome of new Mirapexin®/ Sifrol® (pramipexole) study set to change treatment of depressive symptoms in Parkinson`s disease - For medical media, outside the US only

18.06.2010

Boehringer Ingelheim receives European approval for two new strengths for the once daily tablet formulation of Mirapexin®/Sifrol® prolonged-release for the treatment of Parkinson’s disease

- For non-US Healthcare Media

14.10.2009

Boehringer Ingelheim receives approval from the European Commission for Mirapexin®/Sifrol® prolonged-release, once daily tablet for the treatment of Parkinson`s disease

- For medical media, outside the US only

26.06.2009

Boehringer Ingelheim receives positive recommendation from European scientific committee for a new once daily Mirapexin (pramipexole) formulation for the treatment of Parkinson`s disease

- For medical media, outside the US only

10.06.2009

New data once more show high therapeutic benefits of Boehringer Ingelheim`s Mirapexin®/Sifrol® (pramipexole) once-daily extended release formulation, also in patients with advanced Parkinson`s disease

- For medical media, outside the US only

30.04.2009

Outcome of new Mirapexin®/ Sifrol® (pramipexole) study set to change treatment of depressive symptoms in Parkinson`s disease

- For medical media, outside the US only

Resources
Videos
Images

Parkinson's Disease Related Documents

Parkinson's Disease Video Gallery

Accompanying VNR Parkinson's disease
- Watch the video
A Panoramic Picture of Parkinson's Disease: Professor Werner Poewe speech
- Watch the Video(WMV)
A Panoramic Picture of Parkinson's Disease: Paolo Barone speech
- Watch the video(WMV)
A Panoramic Picture of Parkinson's Disease: Matthias Lemke speech
- Watch the video(WMV)